T. Rowe Price Associates
QTTB icon

T. Rowe Price Associates’s Q32 Bio QTTB Stock Holding History

T. Rowe Price Associates’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,667
Closed -$68K – 2959
2023
Q1 		$68K Hold
3,667
– – ﹤0.01% 2747
2022
Q4 		$83K Hold
3,667
– – ﹤0.01% 2751
2022
Q3 		$107K Hold
3,667
– – ﹤0.01% 2711
2022
Q2 		$130K Sell
3,667
-202
-5% -$6.9K ﹤0.01% 2704
2022
Q1 		$212K Sell
3,869
-124,158
-97% -$7.71M ﹤0.01% 2694
2021
Q4 		$8.39M Buy
128,027
+2,213
+2% +$215K ﹤0.01% 1429
2021
Q3 		$17.8M Hold
125,814
– – ﹤0.01% 1334
2021
Q2 		$16.5M Sell
125,814
-23,723
-16% -$2.96M ﹤0.01% 1344
2021
Q1 		$25.3M Buy
149,537
+39,187
+36% +$8.25M ﹤0.01% 1218
2020
Q4 		$22.4M Sell
110,350
-26,824
-20% -$5.18M ﹤0.01% 1201
2020
Q3 		$26.4M Sell
137,174
-7,604
-5% -$1.7M ﹤0.01% 1076
2020
Q2 		$39.6M Buy
144,778
+7,009
+5% +$1.87M 0.01% 922
2020
Q1 		$38.5M Sell
137,769
-16,644
-11% -$5.1M 0.01% 868
2019
Q4 		$57.5M Sell
154,413
-6,956
-4% -$1.99M 0.01% 866
2019
Q3 		$52.6M Buy
161,369
+52,637
+48% +$17.9M 0.01% 859
2019
Q2 		$38.3M Buy
108,732
+49,720
+84% +$19.5M 0.01% 978
2019
Q1 		$29.5M Buy
59,012
+5,028
+9% +$2.25M ﹤0.01% 1056
2018
Q4 		$21.7M Buy
53,984
+7
+0% +$2.65K ﹤0.01% 1116
2018
Q3 		$22.2M Buy
53,977
+36
+0.1% +$12.2K ﹤0.01% 1190
2018
Q2 		$19.8M Buy
53,941
+25,985
+93% +$9.3M ﹤0.01% 1204
2018
Q1 		$9.41M Buy
+27,956
New +$9.4M ﹤0.01% 1345

Other funds holding QTTB

Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

T. Rowe Price Associates's QTTB Position: Q2 2023 in Review

T. Rowe Price Associates sold out of Q32 Bio (QTTB) in Q2 2023, closing a stake of 3,667 shares — an estimated $68K sold.

T. Rowe Price Associates first reported a position in QTTB in Q1 2018 and held it in 21 quarters. The position peaked at $57.5M in Q4 2019. 59 funds tracked by Wall St. Rank hold QTTB as of Q2 2023.

  • T. Rowe Price Associates reported no remaining Q32 Bio position as of Q2 2023 after selling out during the quarter.
  • T. Rowe Price Associates sold 3,667 Q32 Bio shares in Q2 2023, an estimated $68K.
  • T. Rowe Price Associates first reported a position in Q32 Bio in Q1 2018 and held it in 21 quarters.
  • T. Rowe Price Associates's Q32 Bio position peaked at $57.5M in Q4 2019.
  • 59 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2023.

Based on T. Rowe Price Associates's 13F filing for Q2 2023, filed 14 Aug 2023.